Metabolic Engineering of Acinetobacter baylyi ADP1 for L ‐Leucine Production
Journal of Basic Microbiology · 2026
DOI: 10.1002/jobm.70075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Basic Microbiology, 2026. Verfasst von Wen Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, Newworld Institute of Biotechnology, East China University of Science and Technology, Shanghai, China. Hauptthemen laut MEDLINE: Leucine, Metabolic Engineering, Acinetobacter. Die Arbeit nennt 37 Literaturangaben. Gefördert von: This study was supported by the National Key Research and Development Program of China (2022YFA0912200), the National Natural Science Foundation of China (No.….
Abstract (Originalsprache)
Acinetobacter baylyi ADP1 has garnered attention as a promising synthetic biology chassis due to its compact genome, rapid growth, innate competence for horizontal gene transfer, and ease of genetic manipulation. To assess its potential for natural product biosynthesis, we engineered ADP1 for the production of l ‐leucine. First, feedback inhibition was relieved by overexpressing the endogenous leuA and ilvBN genes, alongside the replacement of transcriptional attenuation regions within the leuBCD operon. These interventions derepressed the native biosynthetic pathway, resulting in a substantial increase in l ‐leucine titers from 0.10 to 0.82 g/L. Next, we augmented the eda gene in the Entner–Doudoroff pathway, while disrupting poxB , which diverts carbon toward acetate, further promoting l ‐leucine biosynthesis. To resolve carbon competition between the tricarboxylic acid (TCA) cycle and l ‐leucine synthesis, an inducible sRNA‐based system was developed to dynamically repress TCA cycle‐associated genes. This balanced the cell growth with l ‐leucine anabolism, ultimately achieving a titer of 1.16 g/L with a yield of 0.08 g/g glucose. Interestingly, the l ‐leucine feedback regulation diverges markedly from classical prokaryotic chassis like Escherichia coli and Corynebacterium glutamicum , in which feedback‐resistant variants of leuA and ilvBN are typically required to overcome repression. In contrast, in ADP1, overexpression of the native, wild‐type genes was sufficient to drive efficient product synthesis. Moreover, the unique glucose catabolism network in ADP1 limits its pyruvate availability, supplementing pyruvate and minimizing carbon loss proved critical for optimizing l ‐leucine production. Collectively, our findings offer mechanistic insights into chassis‐specific metabolic regulation and optimizing precursor supply in nonmodel organisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioreactor Engineering, Newworld Institute of Biotechnology, East China University of Science and Technology, Shanghai, China.
- Department of General Surgery, Jinshan Central Hospital Affiliated to Shanghai University of Medicine and Health Sciences, Shanghai, China.
- Yancheng Institute of Technology, College of Marine and Biology Engineering, Yancheng, Jiangsu, China.
- Anhui Huaheng Biotechnology Co. Ltd., Hefei, Anhui, China.
ORCID-Profile: Feng-Qing Wang, Liang-Bin Xiong
Förderung
- This study was supported by the National Key Research and Development Program of China (2022YFA0912200), the National Natural Science Foundation of China (No.…
Zitieren
APA
Yu, W., Yu, D., Xiong, M., Liu, Y. J., Wang, F. Q., & Xiong, L. B. (2026). Metabolic Engineering of Acinetobacter baylyi ADP1 for L ‐Leucine Production. Journal of Basic Microbiology. https://doi.org/10.1002/jobm.70075
Vancouver
Yu W, Yu D, Xiong M, Liu YJ, Wang FQ, Xiong LB. Metabolic Engineering of Acinetobacter baylyi ADP1 for L ‐Leucine Production. Journal of Basic Microbiology. 2026. doi:10.1002/jobm.70075
BibTeX
@article{Yu2026,
author = {Yu, Wen and Yu, Dong and Xiong, Min and Liu, Yong-Jun and Wang, Feng-Qing and Xiong, Liang-Bin},
title = {Metabolic Engineering of Acinetobacter baylyi ADP1 for L ‐Leucine Production},
journal = {Journal of Basic Microbiology},
year = {2026},
doi = {10.1002/jobm.70075}
}
EUVIMED